| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 1273 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 1273 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1273 |
| 3 | METHOTREXATE SODIUM | 962 |
| 4 | METHOTREXATE | 896 |
| 5 | BUSULFAN | 875 |
| 6 | FLUDARABINE PHOSPHATE | 843 |
| 7 | CYTARABINE | 701 |
| 8 | TACROLIMUS | 645 |
| 9 | ETOPOSIDE | 632 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETIBEGLOGENE AUTOTEMCEL | 7 | 0.1346 |
| 1 | DYCLONINE HCL, MENTHOL, AND PECTIN | 1 | 0.1111 |
| 2 | DEFIBROTIDE SODIUM | 336 | 0.0948 |
| 3 | INOTUZUMAB OZOGAMICIN | 258 | 0.0878 |
| 4 | GEMTUZUMAB OZOGAMICIN | 259 | 0.0713 |
| 5 | BUSULFAN | 875 | 0.0559 |
| 6 | THIOTEPA | 403 | 0.0424 |
| 7 | LOVOTIBEGLOGENE AUTOTEMCEL | 1 | 0.0400 |
| 8 | DACTINOMYCIN | 75 | 0.0342 |
| 9 | THIOGUANINE | 67 | 0.0319 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 1908 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1147 |
| 2 | Corticosteroid [EPC] | 906 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 897 |
| 4 | Platinum-based Drug [EPC] | 890 |
| 5 | Topoisomerase Inhibitor [EPC] | 638 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 436 |
| 7 | Azole Antifungal [EPC] | 369 |
| 8 | Bile Acid [EPC] | 286 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 274 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 258 | 0.0878 |
| 1 | CD33-directed Immunoconjugate [EPC] | 259 | 0.0713 |
| 2 | Actinomycin [EPC] | 75 | 0.0342 |
| 3 | Hematopoietic Stem Cell Mobilizer [EPC] | 33 | 0.0225 |
| 4 | Bile Acid [EPC] | 286 | 0.0128 |
| 5 | Asparagine-specific Enzyme [EPC] | 145 | 0.0110 |
| 6 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 4 | 0.0103 |
| 7 | Echinocandin Antifungal [EPC] | 74 | 0.0093 |
| 8 | Topoisomerase Inhibitor [EPC] | 638 | 0.0083 |
| 9 | Alkylating Drug [EPC] | 1908 | 0.0080 |